There was no statistically significant difference in TDP in 127 men treated with bicalutamide/dutasteride ( n = 62 ) compared with bicalutamide/placebo ( n = 65 ) ( hazard ratio ( HR ) = 0.94 [ 95 % confidence interval ( CI ) 0.61 , 1.46 ] ; p = 0.79 ) .